Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
770.180.39%
QQQ
719.280.22%
BTC/USD
79817.871.7942%
DIA
534.020.54%
GLD
406.680.86%
TLT
82.180.13%

Lumexa Imaging Holdings Inc

LMRINASDAQ
Trade with Public
Trade with Public
$12.14
0.242.02%
At close: Sep 4, 5:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Lumexa Imaging Hldgs Analyst Price Targets

Wall Street analyst price targets and consensus rating for Lumexa Imaging Hldgs (LMRI).

Price Target Range — 3 Quarters

Analyst Consensus — 7 Analysts

1S.Buy
6Buy
Consensus RatingOverweight# Analysts7Avg. Consensus PT$21Upside to Avg. PT+75.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 28, 2026BarclaysAndrew MokPT RaiseOverweight$9→$13
May 20, 2026BarclaysAndrew MokPT CutOverweight$15→$9
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Raises Price Target to $13

Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and raises the price target from $9 to $13.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $9

Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and lowers the price target from $15 to $9.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $15

Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and lowers the price target from $23 to $15.
Benzinga Newsdesk

PRO
Raymond James Upgrades Lumexa Imaging Holdings to Strong Buy, Announces $23 Price Target

Raymond James analyst John Ransom upgrades Lumexa Imaging Holdings (NASDAQ:LMRI) from Outperform to Strong Buy and announces $23 price target.
Benzinga Newsdesk

Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO

Wall Street analysts initiate coverage on Lumexa Imaging, citing advanced imaging growth, expanding centers, and a resilient sales model.
Vandana Singh

PRO
Raymond James Initiates Coverage On Lumexa Imaging Holdings with Outperform Rating, Announces Price Target of $23

Raymond James analyst John Ransom initiates coverage on Lumexa Imaging Holdings (NASDAQ:LMRI) with a Outperform rating and announces Price Target of $23.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved